The latest research, news, and more from GeoInvesting for BioSyent Inc. (BIOYF) /companies/bioyf_biosyent_inc_/overview en-us Wed, 29 Apr 2026 19:47:36 GMT Wed, 29 Apr 2026 19:47:36 GMT 120 62835Mon, 20 May 2024 13:33:02 GMTBioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty, and international business units. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella./companies/bioyf_biosyent_inc_/overview